Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ENXTLS:SCT
ENXTLS:SCTAuto

European Dividend Stocks To Consider For Your Portfolio

As the European markets navigate a period of volatility, with the STOXX Europe 600 Index remaining relatively stable despite global tech sector weaknesses and rising oil prices, investors are increasingly looking towards dividend stocks as a source of steady income. In such an environment, selecting stocks that offer reliable dividends can provide portfolio stability and potential growth amidst broader market fluctuations.
NYSE:TFIN
NYSE:TFINBanks

How Investors May Respond To Triumph Financial (TFIN) Q2 2026 Results And Revenue Growth Acceleration

Triumph Financial, Inc. reported its Q2 2026 results after market close on July 21, 2026, following a prior quarter in which it missed analyst revenue expectations but still grew revenue 4.7% year on year to US$105.5 million. Investor attention is now centered on whether Triumph Financial’s Q2 report aligns with market expectations for improved 7% year-on-year revenue growth compared with the 2.2% increase in the same quarter last year. We’ll now examine how the anticipated acceleration in...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

What UroGen Pharma (URGN)'s UGN-501 IND Clearance Means For Shareholders

UroGen Pharma recently reported that the U.S. Food and Drug Administration cleared its Investigational New Drug application for UGN-501, a next-generation oncolytic virus for non-muscle invasive bladder cancer, allowing a Phase 1 trial of intravesical administration focused on safety, tolerability, and feasibility to begin. This IND clearance adds a new oncolytic immunotherapy candidate to UroGen’s uro-oncology pipeline, potentially broadening its future reach beyond bladder cancer into...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Will Pega Infinity 26’s Flat-Fee AI Model Change Pegasystems' (PEGA) Recurring Revenue Narrative?

Pegasystems recently launched Pega Infinity 26, an AI suite that combines agentic AI, built-in governance, and flat-fee, case-based pricing to help enterprises scale AI adoption with greater control over compliance and costs. This release, which integrates with multiple third-party coding agents and AI assistants, positions Pega’s platform as a tightly governed hub for end-to-end AI-driven workflows across development, operations, and customer engagement. Now we’ll explore how Pega Infinity...
TSE:3401
TSE:3401Chemicals

Teijin (TSE:3401) Looks Slightly Undervalued, Is The Recent Rally Already Priced In?

Teijin stock reaction and recent performance With no single headline event driving Teijin (TSE:3401) today, investors are focusing on the stock’s recent returns, its current valuation signals, and how its diversified materials and healthcare exposure might fit into portfolios. See our latest analysis for Teijin. Recent trading reflects that Teijin’s share price return of 5.9% over the past month and 25.9% year to date has been strong, while the 1 year total shareholder return of 45.4% points...
NasdaqGS:CENX
NasdaqGS:CENXMetals and Mining

Century Aluminum (CENX) On Oklahoma Smelter Push, Bargain Or Fairly Priced

Century Aluminum (CENX) is in focus after a new U.S. executive order offered tariff incentives for domestic primary aluminum projects, coinciding with its plan to build a large Oklahoma smelter in partnership with Emirates Global Aluminum. See our latest analysis for Century Aluminum. At a share price of $42.84, Century Aluminum has seen short term pressure, with the 30 day share price return down 17.15% and the 90 day share price return down 30.23%, even as the 1 year total shareholder...
NasdaqGM:SION
NasdaqGM:SIONBiotechs

Sionna Therapeutics (SION) Pulls Back On CF Hopes With Valuation Still In Focus

Sionna Therapeutics (SION) stock has been moving on the back of its clinical-stage cystic fibrosis portfolio, with several candidates reported as having completed Phase 1 or Phase 2 trials and a market value around $2.23 billion. See our latest analysis for Sionna Therapeutics. Sionna Therapeutics’ recent pullback, with a 1 day share price return of down 7.53% to $45.69, comes after a strong run that includes a 30 day share price return of 22.49% and a 1 year total shareholder return of...
SHSE:688256
SHSE:688256Semiconductor

Cambricon Stock And 2 China AI Chip Plays In Focus After Kimi K3

A sharp sell-off in global AI stocks, a nearly 4% slide in South Korea’s KOSPI and a fresh surge in oil prices above US$90 per barrel have pushed investors to reassess how exposed their portfolios are to fast changing themes. Chinese artificial intelligence and semiconductor stocks have stood out in this volatility, with domestic equities and chip firms holding up better than some regional peers after the launch of China’s Moonshot AI Kimi K3 model. This article walks through 3 stocks from...
NYSE:HSY
NYSE:HSYFood

Hershey Stock And 2 Consumer Staples Picks For Stretched Household Budgets

With U.S. credit card delinquencies at a 15 year high and household debt climbing to a record $1.25b, many investors are asking which parts of the market might hold up better if consumer finances stay under pressure. Consumer staples stocks, especially larger dividend payers with stable risk profiles, are often seen as potential anchors when budgets tighten. This article looks at three stocks from our Consumer Staples Stocks screener that are directly exposed to the latest credit stress...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq’s Expanding Fintech Role Reshaping The Investment Case For NDAQ?

Nasdaq Inc. recently implemented changes to the parent indices behind several Xtrackers (IE) plc funds and announced a partnership to modernize Georgia’s financial markets infrastructure using its Calypso platform. These moves, alongside analysts’ expectations for higher quarterly revenue and earnings driven by Financial Technology and Capital Access Platforms, highlight Nasdaq’s growing role as a technology provider to global capital markets. We’ll now examine how anticipated earnings...
NYSE:KLAR
NYSE:KLARDiversified Financial

What Klarna Group (KLAR)'s New Travel Partnerships With Southwest And Flix Mean For Shareholders

In July 2026, Flix SE and Southwest Airlines Co. announced expanded partnerships with Klarna Group plc, integrating Klarna’s pay-in-full, interest-free installment, and longer-term financing options into their booking platforms across the U.S. and 21 European markets, while also removing foreign exchange fees on cross-border Flix journeys. These deals deepen Klarna’s presence in high-traffic travel channels, potentially increasing transaction volumes and adoption of its flexible payment and...
NYSE:EXPD
NYSE:EXPDLogistics

3 Reasons Expeditors International of Washington (EXPD) Looks Fully Valued Following Earnings Optimism

Expeditors International of Washington (EXPD) is back in focus after analysts raised earnings estimates ahead of its August second quarter report and the company expanded its global Aircraft on Ground logistics capabilities. See our latest analysis for Expeditors International of Washington. Against this backdrop, Expeditors International of Washington’s share price has climbed 9.95% over the past month and 17.48% over the past 90 days, while its 1 year total shareholder return of 59.25%...
NasdaqGS:CPRT
NasdaqGS:CPRTCommercial Services

Copart (CPRT) Names Jane Pocock President As Investors Ask If The Pullback Is A Buying Opportunity

Copart (CPRT) has moved into focus after the company promoted Jane Pocock to President, a leadership change that connects its UK and Ireland track record with the broader global auction platform. See our latest analysis for Copart. Copart’s latest leadership change comes after a period where the share price has lost momentum, with the 30 day share price return down 9.06% and the year to date share price return down 27.22%, while the 1 year total shareholder return is down 40.28%. This signals...